Page 12 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 12

2     Assurance of sterility for sensitive combination products and materials


             The regulatory evolution of combination products has provided man-
          ufacturers with an opportunity to envision a new subset of products that
          utilize various combinations of medical devices, biologics, pharmaceuticals,
          active electronics, and/or bioresorbables in unique manners. Therefore, the
          regulatory climate for combination products necessitated the use of a blend
          of requirements that would be specific for the appropriate combination of
          medical device, biologics, and/or pharmaceutical products.
             Until recently, healthcare products were typically classified as medical
          devices, biologics, or pharmaceuticals. The different classifications of prod-
          ucts were traditionally regulated through different parts of regulatory agen-
          cies, which have for years operated independently. The requirements for
          different categories of products did not typically involve coordination across
          agencies. The development of combination products has required that man-
          ufacturers as well as regulators learn to navigate the diverse requirements
          across the different agencies.
             A successful sterility assurance professional—with the convergences of
          this changing regulatory landscape—requires the ability to connect the dots
          across the different sectors of the industry that have traditionally, all too
          often, been in silos. Combination products may need terminal sterilization
          and/or aseptic processing; and sterilization professionals need to understand
          both. The majority of healthcare risks to patients include those associated
          with healthcare facilities themselves; hence, sterilization professionals need
          to understand how the product is used in the healthcare facilities and the
          magnitude of hospital-acquired infections (HAI).
             One of the unique value streams of this book is its perspective integrat-
          ing discussion of sterility assurance topics across industry sectors. This pres-
          ents a terminology challenge since different sectors use different but related
          terminology. This is addressed as follows.


          1.2  Sterility assurance terminology

          The term ‘sterile’ is generally defined as an absolute state, for example, the
          absence of viable microorganisms. Different terms are used in different sterility
          assurance sectors as follows:
             Sterility assurance level (SAL) is specific to terminal sterilization, defined
             as the “probability of a single viable microorganism occurring on an
             item after sterilization.”
             Probability of a non-sterile unit (PNSU) is sometimes used for termi-
             nally sterilized components feeding into an aseptic process.
   7   8   9   10   11   12   13   14   15   16   17